Abstract
Disaccharide derivatives in the daunorubicin and in the 4-demethoxy (idarubicin) series in whichthe first sugar moiety linked to the aglycone is a non-aminated sugar, namely 2-deoxy-l-rhamnose or 2-deoxy-l-fucose andthe second moiety is daunosamine, have been obtained upon synthesis of the appropriate activated sugarintermediate and glycosylation of the corresponding aglycones. The compounds containing 2-deoxy-l-fucose exhibit superior pharmacological properties with respect to thestereoisomers containing 2-deoxy-l-rhamnose. The doxorubicinanalog 7-O-(α-l-daunosaminyl-α(1–4)-2-deoxy-l-fucosyl)-4-demethoxy-adriamycinone (sabarubicin) was prepared startingfrom 14-acetoxyidarubicinone. Solution properties and molecular interactions are compared with thoseof doxorubicin. Sabarubicin exhibits a superior antitumor efficacy, presumably related to theactivation of p53-independent apoptosis. A number of sabarubicin analogues have also been synthesized.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brockmann H (1963) Forschr Chem Organ Naturst 21:121
O'Hagan D (1991) The polyketide metabolites. Ellis Horwood, Chichester UK
Arcamone F, Cassinelli G (1998) Curr Med Chem 5:391
Fujii I, Ebizuka Y (1997) Chem Rev 97:2511
Hutchinson CR (1997) Chem Rev 97:2525
Hopwood DA (1997) Chem Rev 97:2465
Arcamone F, Di Marco A, Gaetani M, Scotti T (1961) Giorn Microbiol 9:83
Arcamone F, Franceschi G, Penco S, Selva A (1969) Tetrahedron Lett 1007
Arcamone F (1980) The development of new antitumor anthracyclines. In: Cassady J, Douros J (eds) Anticancer Agents Based on Natural Products Models. Academic, New York, chap 1
Arcamone F (1981) Doxorubicin Anticancer Antibiotics. Academic, New York
Takeuchi T (1995) J Cancer Res Clin Oncol 121:505
Nielsen D, Maare C, Skovsgaard T (1996) Gen Pharmacol 27:255
Weiss RB (1992) Semin Oncol 19:670
Arcamone F, Animati F, Capranico G, Lombardi P, Pratesi G, Manzini S, Supino R, Zunino F (1997) Pharmacol Ther 76:117
Wang AH-J (1992) Curr Opin Struct Biol 2:361
Stutter E, Schuetz H, Berg H (1981) Quantitative determination of cooperative anthracycline-DNA binding. In: Cassady J, Douros J (eds) Anticancer Agents Based on Natural Products Models. Academic, New York, p 245
Ughetto G (1981) X-Ray diffraction analysis of anthracycline-oligonucleotide complexes. In: Cassady J, Douros J (eds) Anticancer Agents Based on Natural Products Models. Academic, New York, p 296
Pullman B (1981) Binding affinities and sequence selectivity in the interaction of antitumor anthracyclines and anthracenediones with double stranded polynucleotides and DNA. In: Cassady J, Douros J (eds) Anticancer Agents Based on Natural Products Models. Academic, New York, p 371
Chaires JB, Herrera JE, Waring JM (1990) Biochemistry 29:6145
Frederick CA, Williams LD, Ughetto G, van der Marel GA, van Boom JH, Rich A, Wang AH-J (1990) Biochemistry 29:2538
Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF (1984) Science 226:466
Capranico G, Zunino F, Kohn KW, Pommier Y (1990) Biochemistry 29:562
Capranico G, Kohn KW, Pommier Y (1990) Nucleic Acids Res 22:6611
Zunino F, Capranico G (1990) Anticancer Drug Des 4:307
Binaschi M, Capranico G, Dal Bo L, Zunino F (1997) Mol Pharmacol 6:1053
Gerwitz DA (1992) Biochem Pharmacol 57:727
Ishikawa T, Sies H (1984) J Biol Chem 239:3838
Formelli F, Zedeck MS, Sternberget SS, Philips FS (1978) Cancer Res 38:3286
Ellis CN, Ellis MB, Blakemore WS (1987) Biochem J 245:309
Ito H, Miller SC, Billingham ME, Akimoto H, Torti SV, Wade R, Gahlmann R, Lyons G, Kedes L, Torti FM (1990) Proc Natl Acad Sci USA 87:4275
Arcamone F, Penco S (1989) Gann Monographs Cancer Res 36:81
Capranico G, De Isabella P, Penco S, Tinelli S, Zunino F (1989) Cancer Res 49:2022
Capranico G, Supino R, Binaschi M, Capolongo L, Grandi M, Suarato A, Zunino F (1994) Mol Pharmacol 45:908
Gresh N, Pullman B, Arcamone F, Menozzi M, Tonani R (1988) Mol Pharmacol 35:251
Boivin J, Monneret C, Pais M (1981) Tetrahedron 37:4219
El Khadem HS, Matsura D (1982) Carboydr Res 101:C1
Horton D, Priebe W, Sznaidman ML, Varela O (1993) J Antibiot 46:1720
Borchmann P, Hubel K, Schnell R, Engert A (1997) Int J Clin Pharmacol Ther 35:80
Animati F, Berettoni M, Cipollone A, Franciotti M, Lombardi P, Monteagudo P, Arcamone F (1996) J Chem Soc Perkin Trans I:1327
Arcamone F, Animati F, Bigioni M, Capranico G, Caserini C, Cipollone A, De Cesare M, Ettorre A, Guano F, Manzini S, Monteagudo E, Pratesi G, Salvatore C, Supino R, Zunino F (1999) Biochem Pharmacol 57:1133
Arcamone F, Animati F, Berettoni M, Bigioni M, Capranico G, Casazza AM, Caserini C, Cipollone A, De Cesare M, Franciotti M, Lombardi P, Madami A, Manzini S, Monteagudo E, Polizzi D, Pratesi G, Righetti SC, Salvatore C, Supino R, Zunino F (1997) J Nat Cancer Inst 89:1217
Monteagudo E, Madami A, Animati F, Lombardi P, Arcamone F (1997) Carbohydr Res 300:11
Ragg E, Mondelli R, Penco S (1988) J Chem Soc Perkin Trans II:1673
Cicero DO, Barbato G, Bazzo R (1995) J Am Chem Soc 117:1027
Messori L, Temperini C, Piccioli F (2001) Bioorg Med Chem 9:938
Temperini C, Messori L, Orioli P, Di Bugno C, Animati F, Ughetto G (2003) Nucleic Acids Res 31:1464
Bos AME, De Vries EGE, Dombernovsky P, Aamdal S, Uges DRA, Shuijvers D, Wanders J, Roelwink MWJ, Hanauske AR, Bortini S, Capriati A, Crea AEG, Vermorken JB (2001) Cancer Chemother Pharmacol 48:361
Messori L, Piccioli F, Gabrielli S, Orioli P, Angeloni L, Di Bugno C (2002) Bioorg Med Chem 10:3425
Pratesi G, De Cesare M, Caserini C, Perego P, Supino R, Bigioni M, Manzini S, Iafrate E, Salvatore C, Casazza AM, Arcamone F, Zunino F (1998) Clin Cancer Res 4:2833
Pratesi G, Polizzi D, Perego P, Dal Bo L, Zunino F (2000) Biochem Pharmacol 60:77
Bigioni M, Salvatore C, Bullo A, Bellarosa D, Iafrate E, Animati F, Capranico G, Goso C, Maggi CA, Pratesi G, Zunino F, Manzini S (2001) Biochem Pharmacol 62:63
Gonzales-Paz O, Polizzi D, De Cesare M, Zunino F, Bigioni M, Maggi CA, Manzini S, Pratesi G (2001) Eur J Cancer 37:431
Cirillo R, Sacco G, Venturella S, Brightwell J, Giachetti A, Manzini S (2000) Cardiovasc Pharmacol 35:100
Zucchi R, Yu G, Ghelardoni S, Ronca F, Ronca-Testoni S (2000) Brit J Pharmaco1 131:342
Roelvink M, Aamdal S, Dombernowsky P, Wanders J, Peters S, Bortini S, Crea A, Animati F, Hanauske AR (1999) Eur J Cancer 35(Suppl 4):1161
Schrivers D, Bos AME, Dyck J, de Vries EGE, Wanders J, Roelvik M, Fumoleau P, Bortii S, Vermorke JB (2002) Ann Oncol 13:385
Tjan-Heijnen VCG, Gerritsen A, ten Valde GPM, Giaccone G, Gamucci T, Comandini A, Capriati A, Mordiva A, Nurmohamed S, Ruland-Adank S (2002) Ann Oncol 13(Suppl 5):148
Dickgreber NJ, Welte T, Gillissen A, Dunlop D, Eberhardt W, Wagner T, Swinson D, Capriati A, O'Byrne K (2003) Proc Am Soc Clin Oncol 22:703
Caponigro F, Willems P, Sorio R, Floquet A, van Belle S, Demol J, Tambaro R, Comandini A, Capriati A, Adank S, Wanders J (2005) Invest New Drugs 23:85
Fiedler W, Tchen N, Bloch J, Fargeot P, Sorio R, Vermorken JB, Collette L, Lacombe D, Twelves C (2006) Eur J Cancer 42:200
Cipollone A, Berettoni M, Bigioni M, Binaschi M, Cermele C, Monteagudo E, Olivieri L, Palomba D, Animati F, Goso C, Maggi CA (2002) Bioorg Med Chem 10:1459
Bigioni M, Salvatore C, Cipollone A, Berettoni M, Maggi CA, Binaschi M (2005) Lett Drug Design Discovery 2:68
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Arcamone, FM. (2007). Sabarubicin. In: Krohn, K. (eds) Anthracycline Chemistry and Biology II. Topics in Current Chemistry, vol 283. Springer, Berlin, Heidelberg. https://doi.org/10.1007/128_2007_1
Download citation
DOI: https://doi.org/10.1007/128_2007_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-75812-9
Online ISBN: 978-3-540-75813-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)